AquaBounty was a land-based aquaculture company that grew and sold genetically engineered Atlantic salmon using recirculating aquaculture system (RAS) technology — an indoor, closed-containment farming method. The company's core differentiator was proprietary GE salmon that grew faster than conventional salmon, which it argued would translate into a cost advantage at scale. AquaBounty's intended model was to sell salmon to food distributors and retailers from large-scale RAS facilities. The flagship project was the Ohio Farm, designed to produce 10,000 metric tons of salmon annually. However, cost overruns driven by inflation and rising interest rates pushed the total project cost estimate to roughly $490M, well beyond what the company could finance. Construction halted in mid-2023 with only about 30% of the facility complete. AquaBounty has since sold its Indiana and Canadian operating farms, sold its core GE salmon IP, and is down to 3 employees. The company is now essentially a shell, with its only remaining asset being the partially constructed Ohio Farm site and associated land and equipment. Completing the Ohio Farm as originally designed would require roughly $400M in additional funding. AquaBounty's near-term future depends entirely on its ability to sell the Ohio Farm site — the company has received a non-binding letter of interest for the Ohio subsidiary and is actively exploring a transaction.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →